which one is better semaglutide or tirzepatide vs Semaglutide vs. Tirzepatide: What's the

Reveals Body Weight Control by Endogenous GLP-1

Combined use of the two drug classes may enhance clinical outcomes in DKD

Thats why the low-dose approach has become such an appealing option

After 6 months of therapy, those taking GLP1 drugs showed: Elevated risk of androgenic alopecia Elevated risk of nonscarring hair loss No significant change in telogen effluvium risk No significant change in alopecia areata risk At the 12-month mark, the pattern had shifted slightly: Continued higher risk for androgenic alopecia Continued higher risk for nonscarring hair loss A newly increased risk of telogen effluvium Still no change in risk of alopecia areata The apparent absence of a link between GLP1 medications and alopecia areata is especially notable, as isolated case reports have previously suggested an association

This hormone increases feelings of fullness, reduces hunger, and slows down the emptying of the stomach, leading to reduced calorie intake and gradual weight loss